ArticlePLoS neglected tropical diseases2025
Identifying gaps in the care and management of NTD morbidity, disability and disfigurement in Africa.
Article in PLoS neglected tropical diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neglected Tropical Diseases Elimination in the Philippines: Challenges and Gaps.Tropical medicine and infectious disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundNeglected tropical diseases (NTDs) affect about 1.7 billion people worldwide, with the highest burden in sub-Saharan Africa. While global initiatives have reduced infection prevalence, the chronic impacts of NTDs, including morbidity, disability, and disfigurement, remain severely neglected, perpetuating poverty, social exclusion, and mental health challenges. This study aimed to identify gaps in care and management for individuals living with chronic NTD-related disabilities and to validate the situational analysis findings through participatory workshops. METHODOLOGY/PRINCIPAL
findingsA mixed-methods approach was employed, comprising a situational analysis of national policies, healthcare services, and control strategies across the World Health Organization (WHO) African Region, complemented by participatory workshops, including focus group discussions (FGDs) and in-depth interviews (IDIs) with affected individuals and stakeholders, in Zimbabwe and Tanzania. Qualitative data were thematically analysed to capture key challenges, including healthcare access barriers, stigma, and gaps in care and management. The situational analysis revealed critical gaps in chronic NTD care, including lack of comprehensive policies for NTD disability management, fragmented health services, limited access to rehabilitation and mental health support, and where available at all, weak integration of morbidity management into national health systems. Findings from FGDs and IDIs corroborated these findings, highlighting barriers to healthcare access, policy deficiencies, socioeconomic burden, deep-rooted stigma, and psychological distress. Participants emphasised the urgency of integrating chronic care into national health systems, strengthening service delivery, and ensuring financial protection. CONCLUSIONS/SIGNIFICANCE: Current NTD programs prioritise infection control and disease elimination while neglecting long-term disability management. To ensure end-to-end health service provision, it is imperative to integrate morbidity management, disability support, psychosocial support, and rehabilitation into existing healthcare frameworks, informed directly by the voices of those affected. Ultimately, by bridging the gaps between policy, healthcare, and community engagement, and mainstreaming NTD morbidity management, we can ensure that individuals affected by NTDs receive comprehensive, long-term support, and that progress in disease control translates into sustained improvements in well-being.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.